Patients Over 80 Still Benefit From Treatment for AML Blood Cancer

TUESDAY, May 14, 2024 -- Seniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted therapy for the blood cancer, a new study finds.

The oral drug venetoclax is typically given to older AML patients whose...